Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
Pelthos Therapeutics was added to the Russell 3000E™ Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark indexes effective at market open on June 29, 2026, as part of the annual Russell indexes reconstitution. Inclusion in the Russell Microcap® Index also means automatic membership in the appropriate growth and value style indexes. Beginning in 2026, Russell US Indexes are reconstituted semi-annually, and membership remains in place until the next scheduled reconstitution. CEO Scott Plesha said the inclusion reflects significant progress since becoming a public company and is expected to enhance visibility within the investment community.
Key figures
- Russell assets benchmarked
- $12.2 trillion
- Ftse russell assets benchmarked
- $21.20 trillion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.